Английская Википедия:BriLife

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Use dmy dates Шаблон:Expand Hebrew Шаблон:Infobox drug Шаблон:COVID-19 pandemic sidebar BriLife, also known as IIBR-100, is a replication-competent recombinant VSV viral vectored COVID-19 vaccine candidate.[1][2][3][4] It was developed by the Israel Institute for Biological Research (IIBR).[1][5][6] The IIBR partnered with the US-based NRx Pharmaceuticals to complete clinical trials and commercialize the vaccine.[7][8] A study conducted in hamsters suggested that one dose of the vaccine was safe and effective at protecting against COVID-19.[9][3]

References

Шаблон:Reflist

External links

Шаблон:ScholiaШаблон:Commons categoryШаблон:Vaccines Шаблон:COVID-19 pandemic Шаблон:Portal bar

Шаблон:Vaccine-stub Шаблон:COVID19-vaccine-stub